Observational study of using lactate dehydrogenase as prognostic marker in dengue patients

一项关于乳酸脱氢酶作为登革热患者预后标志物的观察性研究

阅读:1

Abstract

BACKGROUND: Dengue is one of the common mosquito borne illnesses in south India and it is nearly endemic in these coastal states. In view of high incidence during monsoon season with substantial mortality, the department of Internal Medicine performed a study where serum Lactate dehydrogenase levels were used as biomarker to predict severity of dengue infection to avoid complications and mortality. METHODS: The study was an unicentric, open labelled, observational prospective study conducted in a tertiary care hospital of the coastal region. All the patients who were serologically tested with Dengue positive status during June 2022 to December 2022 were included in the study. RESULTS: The correlation between lactate dehydrogenase (LDH) levels at the time of presentation and severity of disease is linear in nature with Pearson's coefficient of correlation (R) 0.778. The linear correlation was statistically significant with P value < 0.01. The correlation between LDH levels at the time of presentation and platelet count at time of admission was inversely proportional with Pearson's coefficient of correlation (R) - 0.326. CONCLUSION: The main finding of the study is that LDH levels at the time of diagnosis in dengue patients can predict complications during course of illness.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。